Inflammatory response in islet transplantation.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 4021753)

Published in Int J Endocrinol on April 30, 2014

Authors

Mazhar A Kanak1, Morihito Takita2, Faisal Kunnathodi2, Michael C Lawrence2, Marlon F Levy3, Bashoo Naziruddin3

Author Affiliations

1: Institute for Biomedical Studies, Baylor University, Waco, TX 76712, USA.
2: Islet Cell Laboratory, Baylor Research Institute, Dallas, TX 75204, USA.
3: Baylor Annette C. and Harold C. Simmons Transplant Institute, 3410 Worth Street, Dallas, TX 75246, USA.

Articles cited by this

(truncated to the top 100)

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26

Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76

Secretory products of macrophages. J Clin Invest (1987) 10.33

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol (1993) 7.42

Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A (1997) 4.74

Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A (1997) 4.63

NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev (2008) 4.61

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA (2005) 4.48

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A (2006) 4.08

Life with oxygen. Science (2007) 3.88

Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med (1996) 3.35

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant (2005) 3.07

HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96

Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature (2006) 2.96

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (1986) 2.83

Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76

Chronic pancreatitis. Lancet (2011) 2.42

A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol (2006) 2.13

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant (2012) 2.12

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06

Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol (2008) 2.01

Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci U S A (1991) 2.00

Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol (2005) 2.00

Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia (1973) 1.98

Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer (1995) 1.96

Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation (2008) 1.80

Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med (2008) 1.74

Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant (2008) 1.73

Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell (2012) 1.72

Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes (2001) 1.71

Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med (2002) 1.69

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant (2008) 1.68

Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65

Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes (2003) 1.63

Bone marrow as an alternative site for islet transplantation. Blood (2009) 1.61

Effect of short-term culture on functional and stress-related parameters in isolated human islets. Transpl Int (2008) 1.55

Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes (2004) 1.55

Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation (2001) 1.54

Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes (2002) 1.52

ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem (2005) 1.48

Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci (1997) 1.45

Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes (2001) 1.43

Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes (2001) 1.43

Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc (1988) 1.43

Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes (1998) 1.40

Cloning and characterization of the 5'-transcriptional regulatory region of the human intercellular adhesion molecule 1 gene. J Biol Chem (1991) 1.40

Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med (1995) 1.40

Update on islet transplantation. Cold Spring Harb Perspect Med (2012) 1.40

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38

Natural history of intrahepatic canine islet cell autografts. J Clin Invest (1986) 1.37

Positron emission tomography in clinical islet transplantation. Am J Transplant (2009) 1.37

Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J Biol Chem (2003) 1.33

Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc Natl Acad Sci U S A (1982) 1.32

State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep (2011) 1.30

Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med (1998) 1.30

Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med (2001) 1.29

Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28

Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes (2008) 1.26

Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26

Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant (2005) 1.24

Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes (2007) 1.24

Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in beta-cells. Proc Natl Acad Sci U S A (2008) 1.23

High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J Clin Invest (2010) 1.21

NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A (2007) 1.19

Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes (1998) 1.19

Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant (2011) 1.18

IKK/NF-kappaB signaling in intestinal epithelial cells controls immune homeostasis in the gut. Mucosal Immunol (2008) 1.15

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes (2013) 1.15

Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes (2003) 1.14

Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes (1999) 1.13

Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS One (2012) 1.13

Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. J Biol Chem (2010) 1.12

Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation (2008) 1.12

Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia. Cell Transplant (2005) 1.11

Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant (2011) 1.10

Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia (2005) 1.06

CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Invest (2012) 1.05

Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost (2001) 1.04

Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production. J Clin Invest (1998) 1.04

Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule. J Surg Res (1988) 1.04

Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J Immunol (2003) 1.03

Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation (2008) 1.03

Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation (2004) 1.03

Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. J Biol Chem (2009) 1.03

Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J Neurosci (1998) 1.02

Role of CCL2/MCP-1 in islet transplantation. Cell Transplant (2010) 1.01

Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant (2006) 1.01

Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia (2005) 1.01

Chronic pancreatitis. Am Fam Physician (2007) 1.01

Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes (2002) 1.00

Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation (2008) 1.00

Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery (2003) 1.00

Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00

Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant (2011) 0.98

Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation. Am J Transplant (2014) 0.98

The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation (2006) 0.98

Autologous pancreatic islet transplantation in human bone marrow. Diabetes (2013) 0.97

Improvement of human islet cryopreservation by a p38 MAPK inhibitor. Am J Transplant (2007) 0.97

Activation and expression of ERK, JNK, and p38 MAP-kinases in isolated islets of Langerhans: implications for cultured islet survival. FEBS Lett (1999) 0.97